230 related articles for article (PubMed ID: 26855418)
1. The neutral sphingomyelinase-2 is involved in angiogenic signaling triggered by oxidized LDL.
Camaré C; Augé N; Pucelle M; Saint-Lebes B; Grazide MH; Nègre-Salvayre A; Salvayre R
Free Radic Biol Med; 2016 Apr; 93():204-16. PubMed ID: 26855418
[TBL] [Abstract][Full Text] [Related]
2. Oxidized LDL-induced angiogenesis involves sphingosine 1-phosphate: prevention by anti-S1P antibody.
Camaré C; Trayssac M; Garmy-Susini B; Mucher E; Sabbadini R; Salvayre R; Negre-Salvayre A
Br J Pharmacol; 2015 Jan; 172(1):106-18. PubMed ID: 25176316
[TBL] [Abstract][Full Text] [Related]
3. A signaling cascade mediated by ceramide, src and PDGFRβ coordinates the activation of the redox-sensitive neutral sphingomyelinase-2 and sphingosine kinase-1.
Cinq-Frais C; Coatrieux C; Grazide MH; Hannun YA; Nègre-Salvayre A; Salvayre R; Augé N
Biochim Biophys Acta; 2013 Aug; 1831(8):1344-56. PubMed ID: 23651497
[TBL] [Abstract][Full Text] [Related]
4. Ceramide mediates Ox-LDL-induced human vascular smooth muscle cell calcification via p38 mitogen-activated protein kinase signaling.
Liao L; Zhou Q; Song Y; Wu W; Yu H; Wang S; Chen Y; Ye M; Lu L
PLoS One; 2013; 8(12):e82379. PubMed ID: 24358176
[TBL] [Abstract][Full Text] [Related]
5. Role of sphingosine 1-phosphate in the mitogenesis induced by oxidized low density lipoprotein in smooth muscle cells via activation of sphingomyelinase, ceramidase, and sphingosine kinase.
Augé N; Nikolova-Karakashian M; Carpentier S; Parthasarathy S; Nègre-Salvayre A; Salvayre R; Merrill AH; Levade T
J Biol Chem; 1999 Jul; 274(31):21533-8. PubMed ID: 10419457
[TBL] [Abstract][Full Text] [Related]
6. Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.
Augé N; Maupas-Schwalm F; Elbaz M; Thiers JC; Waysbort A; Itohara S; Krell HW; Salvayre R; Nègre-Salvayre A
Circulation; 2004 Aug; 110(5):571-8. PubMed ID: 15277330
[TBL] [Abstract][Full Text] [Related]
7. 4-Hydroxynonenal Contributes to Angiogenesis through a Redox-Dependent Sphingolipid Pathway: Prevention by Hydralazine Derivatives.
Camaré C; Vanucci-Bacqué C; Augé N; Pucelle M; Bernis C; Swiader A; Baltas M; Bedos-Belval F; Salvayre R; Nègre-Salvayre A
Oxid Med Cell Longev; 2017; 2017():9172741. PubMed ID: 28479957
[TBL] [Abstract][Full Text] [Related]
8. Role of ceramide in activation of stress-associated MAP kinases by minimally modified LDL in vascular smooth muscle cells.
Loidl A; Claus R; Ingolic E; Deigner HP; Hermetter A
Biochim Biophys Acta; 2004 Oct; 1690(2):150-8. PubMed ID: 15469904
[TBL] [Abstract][Full Text] [Related]
9. Oxidized LDL-induced smooth muscle cell proliferation involves the EGF receptor/PI-3 kinase/Akt and the sphingolipid signaling pathways.
Auge N; Garcia V; Maupas-Schwalm F; Levade T; Salvayre R; Negre-Salvayre A
Arterioscler Thromb Vasc Biol; 2002 Dec; 22(12):1990-5. PubMed ID: 12482824
[TBL] [Abstract][Full Text] [Related]
10. Sphingosine-1-phosphate-induced oxygen free radical generation in smooth muscle cell migration requires Galpha12/13 protein-mediated phospholipase C activation.
Roztocil E; Nicholl SM; Davies MG
J Vasc Surg; 2007 Dec; 46(6):1253-1259. PubMed ID: 18155002
[TBL] [Abstract][Full Text] [Related]
11. NAD+/NADH and/or CoQ/CoQH2 ratios from plasma membrane electron transport may determine ceramide and sphingosine-1-phosphate levels accompanying G1 arrest and apoptosis.
De Luca T; Morré DM; Zhao H; Morré DJ
Biofactors; 2005; 25(1-4):43-60. PubMed ID: 16873929
[TBL] [Abstract][Full Text] [Related]
12. Small concentrations of oxLDL induce capillary tube formation from endothelial cells via LOX-1-dependent redox-sensitive pathway.
Dandapat A; Hu C; Sun L; Mehta JL
Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2435-42. PubMed ID: 17717293
[TBL] [Abstract][Full Text] [Related]
13. Plasma membrane reorganization links acid sphingomyelinase/ceramide to p38 MAPK pathways in endothelial cells apoptosis.
Niaudet C; Bonnaud S; Guillonneau M; Gouard S; Gaugler MH; Dutoit S; Ripoche N; Dubois N; Trichet V; Corre I; Paris F
Cell Signal; 2017 May; 33():10-21. PubMed ID: 28179144
[TBL] [Abstract][Full Text] [Related]
14. Withanolide D induces apoptosis in leukemia by targeting the activation of neutral sphingomyelinase-ceramide cascade mediated by synergistic activation of c-Jun N-terminal kinase and p38 mitogen-activated protein kinase.
Mondal S; Mandal C; Sangwan R; Chandra S; Mandal C
Mol Cancer; 2010 Sep; 9():239. PubMed ID: 20836852
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis and activation of the sphingomyelin-ceramide pathway induced by oxidized low density lipoproteins are not causally related in ECV-304 endothelial cells.
Escargueil-Blanc I; Andrieu-Abadie N; Caspar-Bauguil S; Brossmer R; Levade T; Nègre-Salvayre A; Salvayre R
J Biol Chem; 1998 Oct; 273(42):27389-95. PubMed ID: 9765267
[TBL] [Abstract][Full Text] [Related]
16. A key role for matrix metalloproteinases and neutral sphingomyelinase-2 in transplant vasculopathy triggered by anti-HLA antibody.
Galvani S; Trayssac M; Augé N; Thiers JC; Calise D; Krell HW; Sallusto F; Kamar N; Rostaing L; Thomsen M; Nègre-Salvayre A; Salvayre R
Circulation; 2011 Dec; 124(24):2725-34. PubMed ID: 22082680
[TBL] [Abstract][Full Text] [Related]
17. HDL counterbalance the proinflammatory effect of oxidized LDL by inhibiting intracellular reactive oxygen species rise, proteasome activation, and subsequent NF-kappaB activation in smooth muscle cells.
Robbesyn F; Garcia V; Auge N; Vieira O; Frisach MF; Salvayre R; Negre-Salvayre A
FASEB J; 2003 Apr; 17(6):743-5. PubMed ID: 12586748
[TBL] [Abstract][Full Text] [Related]
18. Dual signaling evoked by oxidized LDLs in vascular cells.
Nègre-Salvayre A; Augé N; Camaré C; Bacchetti T; Ferretti G; Salvayre R
Free Radic Biol Med; 2017 May; 106():118-133. PubMed ID: 28189852
[TBL] [Abstract][Full Text] [Related]
19. Role of sphingosine kinase/S1P axis in ECM remodeling of cardiac cells elicited by relaxin.
Frati A; Ricci B; Pierucci F; Nistri S; Bani D; Meacci E
Mol Endocrinol; 2015 Jan; 29(1):53-67. PubMed ID: 25415609
[TBL] [Abstract][Full Text] [Related]
20. Identification and evaluation of neutral sphingomyelinase 2 inhibitors.
Lee DH; Kim SH; Ahn KH; Kim SK; Choi JM; Ji JE; Won JH; Park YH; Lim C; Kim S; Kim DK
Arch Pharm Res; 2011 Feb; 34(2):229-36. PubMed ID: 21380806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
